Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Accelerated vs Standard Approach to Continuous Veno-venous Hemodiafiltration Post-hemoperfusion (ASAP) in Severe Acute Diquat Poisoning [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 3 trial (ASAP) comparing accelerated versus standard continuous veno-venous hemodiafiltration after hemoperfusio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Diquat Poisoning | Phase 3 | Status: NOT_YET_RECRUITING